Why Is BPH Treatment Drug and Surgery Demand Rising Notably?
According to the United Nations Department of Economic and Social Affairs (UNDESA), the number of people aged 65 years or more will grow from 727 million in 2020 to around 1.5 billion by 2050. The U.S. Census Bureau forecasts that the global population of men aged 55–59 years will reach 222,508,188; men within the age group 60–64 years will rise to 198,506,354; and men in the age bracket 65–69 years will surge to 160,741,527 by 2030. As elderly men are highly vulnerable to benign prostatic hyperplasia (BPH), the surging population of geriatric men will help the benign prostatic hyperplasia treatment market flourish during 2021–2030. According to P&S Intelligence, the market revenue will surge from about $10 billion in 2020 to around $17 billion by 2030. BPH or prostate gland enlargement occurs due to bladder or prostate cancer, kidney or bladder stones, urinary tract infections (UTI), scarring in the bladder neck caused due to previous surgeries, urethral stricture, and ...